A biotechnology company whose transgenic mouse and single-B-cell platforms find fully human antibodies, from target validation to early development.
Nona Biosciences
Released September 15, 2026
Antibody language model pretrained on 31.8 million fully human heavy-chain-only antibody sequences from transgenic mouse repertoires.